InvestorsHub Logo
Followers 1
Posts 871
Boards Moderated 0
Alias Born 01/20/2005

Re: ThirdSyte post# 7022

Thursday, 10/17/2019 8:04:38 AM

Thursday, October 17, 2019 8:04:38 AM

Post# of 8201
Good advice. Looking at some Arcaro and Lazar deals post reverse merger,like MXMG, it seems that it's prudent to sell the initial pop, unless the deal is with a really strong company. I noticed a few days ago that GNBT is spinning out their immuno-oncology division into a "pubic vehicle" (i.e. shell)with current filings real soon. Timing is interesting. Could it be BIPH??? LOL. Probably not, but would be great.

https://finance.yahoo.com/news/generex-biotechnology-announces-merger-public-130000860.html